Trial in progress: Phase II study of niraparib and dostarlimab for the treatment of germline or somatic homologous recombination repair mutated metastatic pancreatic cancer.

JOURNAL OF CLINICAL ONCOLOGY(2023)

引用 0|浏览19
暂无评分
关键词
metastatic pancreatic cancer,somatic homologous recombination repair,dostarlimab,niraparib
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要